Perjeta (pertuzumab) 420 mg/14 mL concentrate for solution for infusion — original (Roche, Germany) Breast Cancer Targeted Cancer Therapy.Drug delivery from Europe and beyond, within 4-5 days, storage conditions observed, payment upon receipt. Order by calling +380996042415, Viber, WhatsApp
Delivery methods
- EMC post
Delivery time
- 7-10 days
Payment methods
- Payment to Revolut card
Indications
- Perjeta ® is indicated for use in combination with trastuzumab and docetaxel in adult patients with HER2-positive metastatic or locally recurrent unresectable breast cancer who have not previously received anti-HER2 therapy or chemotherapy for metastatic disease.
- Trade Name:Perjeta
- Chemical Name:pertuzumab
- Dosage:420 mg
- Quantity:1
- Form of Issue:Flacon
- Manufacturer:Roche
No reviews yet
